Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 26, 2023

SELL
$65.71 - $74.53 $26,415 - $29,961
-402 Reduced 12.16%
2,904 $201,000
Q4 2022

Jan 19, 2023

SELL
$68.48 - $81.09 $21,297 - $25,218
-311 Reduced 8.6%
3,306 $238,000
Q3 2022

Oct 27, 2022

SELL
$0.13 - $76.84 $228 - $135,161
-1,759 Reduced 32.72%
3,617 $258,000
Q2 2022

Sep 13, 2022

SELL
$72.62 - $79.98 $416,693 - $458,925
-5,738 Reduced 51.63%
5,376 $414,000
Q1 2022

Sep 13, 2022

BUY
$61.48 - $73.72 $39,962 - $47,918
650 Added 6.21%
11,114 $812,000
Q4 2021

Sep 13, 2022

SELL
$53.63 - $62.52 $4,129 - $4,814
-77 Reduced 0.73%
10,464 $653,000
Q3 2021

Sep 12, 2022

SELL
$59.17 - $69.31 $135,085 - $158,234
-2,283 Reduced 17.8%
10,541 $624,000
Q2 2021

Sep 10, 2021

SELL
$61.91 - $67.42 $28,788 - $31,350
-465 Reduced 3.5%
12,824 $857,000
Q1 2021

Sep 13, 2021

SELL
$59.34 - $66.74 $26,109 - $29,365
-440 Reduced 3.2%
13,289 $839,000
Q4 2020

Sep 20, 2021

BUY
$57.74 - $65.43 $497,661 - $563,941
8,619 Added 168.67%
13,729 $851,000
Q3 2020

Oct 21, 2020

SELL
$57.43 - $63.64 $16,999 - $18,837
-296 Reduced 5.48%
5,110 $308,000
Q2 2020

Jul 21, 2020

BUY
$54.82 - $64.09 $296,356 - $346,470
5,406 New
5,406 $317,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Sunflower Bank, N.A. Portfolio

Follow Sunflower Bank, N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sunflower Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Sunflower Bank, N.A. with notifications on news.